feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Powerball jackpot nears one billion

trending

John Stamos joins Hunting Wives

trending

Taylor Swift Eras Tour docuseries

trending

Wendy Williams guardianship could end

trending

Massachusetts blocks sports prediction market

trending

Detroit schools closed due winter

trending

South Korea: Label AI ads

trending

Conduent data breach millions hit

trending

Moore fired, Shiver scrutinized

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Cream Promises Female Arousal in 10 Minutes

New Cream Promises Female Arousal in 10 Minutes

11 Dec

•

Summary

  • A new topical cream, 'DARE to PLAY,' aims to enhance female sexual arousal.
  • The cream utilizes sildenafil, the active ingredient found in Viagra.
  • It is available for pre-order in 10 U.S. states, with wider release planned.
New Cream Promises Female Arousal in 10 Minutes

Daré Bioscience has introduced 'DARE to PLAY,' a novel topical cream designed to significantly improve sexual arousal for women. This product, costing $10, contains sildenafil, the same active component found in Viagra, and is engineered to increase blood flow to the vaginal area, delivering results in as little as 10 minutes. The company highlights that this development addresses a long-standing gap in sexual medicine for women, aiming to offer a scientifically backed solution for enhancing pleasure and confidence.

The cream is intended for application 10 to 15 minutes prior to sexual activity, with a recommended maximum of one daily use. Clinical trials indicated no side effects compared to a placebo, and the product is manufactured as a Section 503B compounded drug. While such compounded medications are typically not covered by insurance, Daré Bioscience notes that Flexible Spending or Health Savings Account funds may be utilized for payment.

'DARE to PLAY' is currently available for pre-order in Connecticut, Florida, Indiana, Missouri, New Hampshire, New Jersey, Oregon, Pennsylvania, Rhode Island, and Utah, with broader availability anticipated across more states by early 2026. Daré Bioscience continues its efforts toward FDA approval, emphasizing that the cream's effectiveness is supported by extensive research, including toxicology studies and multiple clinical trials.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
DARE to PLAY is a topical cream developed by Daré Bioscience that increases blood flow to the vagina to improve sexual arousal, using sildenafil.
The DARE to PLAY cream is priced at $10 and is available as a compounded medication.
DARE to PLAY is available for pre-order in 10 U.S. states, with wider distribution planned for December and early 2026.

Read more news on

Healthside-arrow

You may also like

Prison Drugs Easier Than Sugar, Coroner Warns

9 Dec • 14 reads

article image

Fake Viagra Sold in Toronto Store, Health Canada Warns

6 Dec • 15 reads

Fredericton Police Overdose Calls Triple

28 Nov • 52 reads

Novo Nordisk Alzheimer's Trial Fails to Slow Decline

24 Nov • 93 reads

article image

Viagra offers clues to reversing rare gene-linked hearing loss

22 Nov • 37 reads

article image